Margie L. Traylor - Jun 14, 2023 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
Director
Signature
/s/ Margie L. Traylor
Stock symbol
AUGX
Transactions as of
Jun 14, 2023
Transactions value $
$119,649
Form type
4
Date filed
6/16/2023, 05:50 PM
Previous filing
May 17, 2023
Next filing
Jul 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Purchase $120K +26.5K +127.54% $4.51 47.3K Jun 14, 2023 Direct F1
transaction AUGX Common Stock Options Exercise +52.6K +111.2% 100K Jun 16, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Restricted Stock Units Options Exercise $0 +52.6K $0.00* 0 Jun 16, 2023 Common Stock 52.6K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $4.47 to $4.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
F3 On June 16, 2022 (the "Grant Date"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date.